In order to use CTC in RCC diagnosis, two problems have to be solved; the immunomarkers capable to define RCC and the non-biased CTC isolation methods regardless of expression of surface protein such as EpCAM are necessary. This evidence concerns the gene EPCAM and renal cell carcinoma.